Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 6/20 | 0.61 |
| ▸ | GCGR | P47871 | 3/20 | 0.61 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.60 |
| ▸ | CALCR | P30988 | 3/20 | 0.59 |
| ▸ | NPY2R | P49146 | 3/20 | 0.58 |
| ▸ | NPY4R | P50391 | 3/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.58 |
| ▸ | NPY1R | P25929 | 2/20 | 0.58 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.57 |
| ▸ | NMBR | P28336 | 2/20 | 0.56 |
| ▸ | GRPR | P30550 | 2/20 | 0.56 |
| ▸ | APLNR | P35414 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29599666 | 0.91 | GLP1R (0.70) | GLP1RGCGRC5AR1CALCRNPY2R | |
| SCHEMBL5069643 | 0.90 | C5AR1 (0.64) | GLP1RGCGRC5AR1NPY2RNPY4R | |
| SCHEMBL23273229 | 0.86 | NMBR (0.69) | GLP1RGCGRC5AR1CALCRNPY2R | |
| SCHEMBL29464570 | 0.85 | NPY2R (0.71) | GLP1RCALCRNPY2RNPY4RNPY5R | |
| SCHEMBL31379433 | 0.85 | NMBR (0.70) | GLP1RGCGRC5AR1CALCRNMBR | |
| SCHEMBL31182594 | 0.85 | CALCR (0.68) | GLP1RGCGRCALCRNPY2RNPY4R | |
| SCHEMBL31182829 | 0.85 | GLP1R (0.73) | GLP1RGCGRC5AR1CALCRNPY2R | |
| SCHEMBL30932062 | 0.84 | GLP1R (0.74) | GLP1RGCGRC5AR1CALCRNPY2R | |
| SCHEMBL30658246 | 0.84 | GLP1R (0.79) | GLP1RGCGRCALCRNPY2RNPY4R | |
| SCHEMBL31083828 | 0.84 | GLP1R (0.70) | GLP1RGCGRC5AR1CALCRNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7375074-B2 | Body weight gain inhibitor | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2008-05-20 | — | — | US | disclosed |
| US-7247440-B2 | Method of screening preventives or remedies for obesity | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-07-24 | — | — | US | disclosed |
| US-20050124539-A1 | Body weight gain inhibitor | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-06-09 | — | — | US | disclosed |
| EP-1459755-A1 | BODY WEIGHT GAIN INHIBITOR | Takeda Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
| EP-1394543-A1 | SCREENING METHOD | Takeda Chemical Industries, Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-20040029178-A1 | Novel g protein-coupled receptor proteins and dnas thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1344823-A1 | NOVEL G PROTEIN-COUPLED RECEPTOR PROTEINS AND DNAS THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2003-09-17 | — | — | EP | disclosed |
| EP-1293567-A1 | LIGAND TO GPR8 AND DNA THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2003-03-19 | — | — | EP | disclosed |